Related Experiment Video
Updated: Aug 2, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
Published on: April 17, 2013
Serum albumin in continuous peritoneal dialysis: absence of universal predictors
A H Tzamaloukas1, E V Balaskas, S Voudiklari
1Veterans Affairs Medical Center, Albuquerque, New Mexico, USA.
Insights
Serum albumin levels in continuous peritoneal dialysis (CPD) patients differ between Greece and the US. Factors predicting low albumin in the US, like age and diabetes, were less effective in Greek patients, suggesting regional differences in CPD management and outcomes.
Area of Science:
- Nephrology
- Clinical Chemistry
Background:
- Serum albumin concentration is a key indicator of nutritional status and prognosis in patients undergoing continuous peritoneal dialysis (CPD).
- Factors influencing serum albumin levels may vary geographically due to differences in patient demographics, comorbidities, and dialysis practices.
Purpose of the Study:
- To compare factors affecting serum albumin concentration in CPD patients between Greece and the United States.
- To evaluate the applicability of a predictive model for hypoalbuminemia developed in the US to a Greek CPD population.
Main Methods:
- A comparative analysis of demographic, clinical, and dialysis-related parameters was performed between Greek (n=108) and US (n=194) CPD patients.
- Logistic regression was used to identify predictors of hypoalbuminemia (serum albumin < 35 g/L) in the US cohort.
- Receiver operating characteristic (ROC) curve analysis was employed to assess the predictive performance of the US model in the Greek cohort.
Main Results:
- Greek CPD patients exhibited higher serum albumin levels (35.1 g/L vs 33.9 g/L), were older, and had higher peritoneal solute transport rates compared to US patients.
- US patients had a higher prevalence of diabetes and superior dialysis adequacy (Kt/Vurea, creatinine clearance).
- The US-based logistic regression model for hypoalbuminemia showed good predictive performance in the US (ROC area 0.850) but significantly poorer performance in Greece (ROC area 0.594).
Conclusions:
- Demographic and clinical factors associated with serum albumin levels in CPD patients differ between Greece and the United States.
- Predictors of hypoalbuminemia identified in North America may not be universally applicable to other global populations.
- Further research is needed to understand the unique factors influencing serum albumin and overall outcomes in diverse CPD populations worldwide.
Abstract:
Factors shown to affect serum albumin concentration in continuous peritoneal dialysis (CPD) were compared between two CPD populations residing in Greece (patient n = 108) and the United States (patient n = 194). Compared to the U.S. group, the Greek CPD population had higher serum albumin levels (35.1 +/- 4.6 vs 33.9 +/- 5.0 g/L, p = 0.031), was older (61.2 +/- 12.0 vs 52.7 +/- 16.5 years, p < 0.001), and had a greater number of high or high-average peritoneal solute transport types (69.4% vs 52.1%, p = 0.003). The American CPD population had a higher number of diabetics (53.1% vs 27.8%, p < 0.001), higher total Kt/Vurea (2.06 +/- 0.57 vs 1.93 +/- 0.46 weekly, p = 0.046), and higher total creatinine clearance (76.3 +/- 38.7 vs 63.4 +/- 23.5 L/1.73 m2 weekly, p < 0.001), while normalized protein nitrogen appearance values were comparable (0.95 +/- 0.21 in the Greeks vs 0.94 +/- 0.22 g/(kg x 24 hr) in the Americans, NS). A logistic regression model developed in the United States identified advanced age, diabetes, and high/high-average peritoneal solute transport as the predictors of hypoalbuminemia (serum albumin < 35 g/L). This model generated the following areas with 95% confidence intervals (CI) under the receiver operating characteristic (ROC) curve: in the Greek CPD population, ROC area 0.594 (95% CI 0.486-0.702); in the American CPD population, ROC area 0.850 (95% CI 0.810-0.890). In Greek CPD patients serum albumin appears to be affected by factors other than those identified in North America. This complicates comparisons of serum albumin, and probably morbidity and mortality, between CPD populations residing in different parts of the world.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

